Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Descartes-08 in Systemic Lupus Erythematosus
NCT06038474Phase 2Active, not recruiting
- Sponsor
- Cartesian Therapeutics
- Start
- Feb 2024
- Primary completion
- Dec 2026
- Modality
- Gene Editing, Prophylactic Vaccines, Gene Silencing
- Countries
- 1
01
Overview
A Phase 2 trial of Descartes-08 in systemic lupus erythematosus (SLE), sponsored by Cartesian Therapeutics. Started Feb 2024; status: active, not recruiting.
02
Drugs
Descartes-08
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT06038474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06038474.